IP Library Granted Patent US 6,927,210
Granted Patent B1
US 6,927,210 · App. 10/048,239 · Granted Aug 9, 2005

Ectoparasiticidal aqueous suspension formulations of spinosyns

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,927,210
App. No.
10/048,239
Granted
Aug 9, 2005
Kind
B1
Abstract

The invention provides a stable ectoparasiticidal aqueous suspension formulation of a spinosyn, comprising the spinosyn, or a physiologically acceptable derivative or salt thereof, milled to an average particle size of 1 to 15 microns, a surfactant in an amount effective to facilitate wetting the milled particles; a dispersant in an amount that forms a spinosyn;dispersant weight ration of from 3:1 to 1:5; and water. It also provides a method of controlling an ectoparasite infestation on a small ruminant or companion animal comprising administering an effective amount of such an aqueous suspension formulation.

Claims (20)

1. A stable ectoparasiticidal aqueous suspension formulation suitable for administration to animals comprising:

a) an ectoparasiticidal amount of spinosad, milled to an average particle size of from 1 to 15 microns;

b) a condensed formaldehyde/naphthalene sulfonic acid or salt thereof dispersant, wherein the spinosad:dispersant weight ratio is 3:1 to 1:5;

c) 0.3 to 5 weight percent of a mineral thickener;

d) an antimicrobial agent acceptable for topical veterinary applications in an amount effective to prevent microbial growth in the suspension;

e) propylene glycol;

f) 0.05 to 3 weight percent of xanthan gum;

g) 0.1 to 10 weight percent of at least one surfactant;

h) an antifoam agent; and

i) water; wherein

said formulation is chemically and physically stable.

2. A formulation of claim 1 wherein the average particle size of spinosad is about 2 to about 7 microns.

3. A formulation of claim 2 wherein the amount of spinosad is from about 0.02 to about 50 weight percent of the formulation.

4. A formulation of claim 3 wherein the amount of spinosad is from about 2 to about 5 weight percent of the formulation.

5. A formulation of claim 4 wherein the surfactant is present in an amount of from about 0.1 to about 5 weight percent of the formulation.

6. A formulation of claim 5 wherein the spinosad is present in an amount of about 25 grams per liter of the formulation.

7. An article of manufacture, comprising packaging material and a formulation for controlling an ectoparasite infestation on a small ruminant or companion animal contained within said packaging material, wherein said formulation comprises:

a unit dose of a formulation of claim 1 ; and wherein said packaging material comprises a label or package insert with instructions for administering the dose to the animal.

8. A method of controlling an ectoparasite infestation on a small ruminant or companion animal, comprising administering to the animal an effective amount of formulation of claim 1 .

9. The method of claim 8 wherein the formulation is applied to the head, neck, shoulders or back of the animal by a spot-on or pour-on protocol.

Assignments (3)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044695/0767 →